Cryoport Acquires Cell&Co BioServices

Excerpt: Cryoport, Inc. (Nasdaq: CYRX) (“Cryoport” or the “Company”), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that it has acquired Cell&Co BioServices, headquartered in Clermont-Ferrand, France with additional operations in Pont-du-Château, France. Founded in 2012, Cell&Co is a bioservices business providing biorepository, kitting, and logistics services to […]

Sanofi breaks ground at S$638 million vaccine facility in Tuas

Excerpt Sanofi broke ground on April 20 on its state-of-the-art vaccine facility in Singapore, which will allow it to quickly pivot to making new vaccines that might be needed to combat future pandemics. Article Summary French healthcare company, Sanofi, broke ground for a vaccine production facility in Singapore, which is expected to create up to […]

Lotte to buy BMS’ biologics plant in Syracuse for $160 mn

Excerpt As part of its first step toward entering the biotech industry, Lotte Group has agreed to purchase Bristol Myers Squibb’s (BMS) biologics plant in Syracuse, New York for $160 million. Article Summary South Korea’s Lotte Group announced that the group has agreed to buy Bristol Myers Squibb’s (BMS) biologics plant in Syracuse in the […]

Cytiva opening new facility in Switzerland

Excerpt Global life sciences leader Cytiva is opening a new 7400m² manufacturing facility in Grens, Switzerland on May 31, 2022. Article Summary Cytiva is opening its latest facility in Grens, Switzerland with over 7400m² in manufacturing area. The site will manufacture consumables for Xuri cell expansion systems and single use kits for the Sepax and […]

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets

Excerpt Bora announced that as part of its five-year growth plan, it will initially invest $50 million USD and up to $100 million USD in the acquisition of Eden Biologics’ CDMO assets in Taiwan. Article Summary Bora Pharmaceuticals, Taiwan’s leading international contract development and manufacturing company (CDMO), has just announced the establishment of Bora Biologics […]

Recipharm completes US biologics acquisitions

Excerpt: Recipharm, a leading global contract development and manufacturing organisation (CDMO), announces the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics.  Article Summary Recipharm announced the acquisition of Arranta Bio and Vibalogics. With this acquisition, Recipharm strengthens its presence in the Biologics market, with a particular focus on drug […]

Harbour BioMed Announces Global Out-License Agreement with AstraZeneca for CLDN18.2xCD3 Bispecific Antibody HBM7022

Excerpt: Harbour BioMed announced a global out-license agreement with AstraZeneca for CLDN18.2xCD3 bispecific antibody (HBM7022), a novel bispecific antibody generated from HBM’s HCAb Based Immune Cell Engagers (HBICE®) Platform.  Article Summary Harbour BioMed out-liscense agreement with AstraZeneca marks a major milestone in Harbour BioMed business development with the agreement and recognition by an industry-leading global […]

Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

Excerpt: FUJIFILM Corporation announced that it has completed the acquisition of a dedicated cell therapy manufacturing facility from Atara Biotherapeutics, Inc. for USD 100 million. Article Summary FUJIFILM has acquired the facility from Atara Biotherapeutics which is located in Thousand Oaks, California. It will be operated as part of FUJIFILM Diosynth Biotechnologies’ global network, which […]

Catalent Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and Across Europe

Excerpt Catalent announced the acquisition from Vaccine Manufacturing and Innovation Centre UK Limited (VMIC Ltd.) of a biologics development and manufacturing facility currently under construction near Oxford, U.K. Article Summary Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple […]

MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer’s in the EU and UK

Excerpt: MGC Pharmaceuticals Ltd. , a European based bio-pharma company specializing in the production and development of phytomedicines, has signed an exclusive distribution agreement with Sciensus Rare, a part of UK health care group, Sciensus, for the distribution of CannEpil® and CogniCann® in key European territories and the UK. Article Summary: The agreement is for […]

Aurobindo Pharma USA Increases Distribution Throughput and Performance with New Automated Warehouse System

Excerpt: When the generic pharmaceutical giant wanted to automate its U.S. nerve center, it sought an automated storage and retrieval system (ASRS) that boosted storage capacity by 450% and increased order fulfillment efficiency. Article Summary: India-based Aurobindo Pharma manufactures and distributes millions of generic pharmaceuticals to more than 150 countries, overseeing a complex, global operation […]

Real-Time In-Transit Visibility: Implications for the Pharma Cold Chain

Excerpt: Recent chaos and uncertainty make a strong use case for real-time, end-to-end visibility at scale in the pharma cold chain. Shippers of high-value urgent, fragile and perishable cargoes need continuous monitoring of shipment location, condition and security. They need to know, preferably in real time, when goods will not arrive on time and in […]